Effect of bevacizumab plus XELOX (CapeOX) chemotherapy on liver natural killer cell activity in colorectal cancer with resectable liver metastasis-Reference-Cited by-同舟云学术

Effect of bevacizumab plus XELOX (CapeOX) chemotherapy on liver natural killer cell activity in colorectal cancer with resectable liver metastasis

Published:2018-07-18 Issue:5 Volume:2 Page:383-393
ISSN:2475-0328
Container-title:Annals of Gastroenterological Surgery
language:en
Short-container-title:Ann Gastroenterol Surg

Author:

Hirata Fumihiro¹,Ishiyama Kohei¹²^ORCID,Tanaka Yuka¹,Kobayashi Tsuyoshi¹,Hashimoto Masakazu¹,Saeki Yoshihiro¹,Ishida Nobuki¹,Taguchi Kazuhiro¹,Tanaka Junko³,Arihiro Koji⁴,Ohdan Hideki¹,

Affiliation:

1. Department of Gastroenterological and Transplant Surgery; Graduate School of Biomedical & Health Sciences; Hiroshima University; Hiroshima Japan

2. Department of Surgery; National Hospital Organization Kure Medical Center and Chugoku Cancer Center; Hiroshima Japan

3. Department of Epidemiology; Infectious Disease Control and Prevention; Graduate School of Biomedical & Health Sciences; Hiroshima University; Hiroshima Japan

4. Department of Anatomical Pathology; Hiroshima University Hospital; Hiroshima Japan

Funder

Japan Agency for Medical Research and Development

Publisher

Wiley

Subject

Gastroenterology,Surgery

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ags3.12195/fullpdf

Reference47 articles.

1. Resection of hepatic metastases from colorectal cancer. Biologic perspective;Steele;Ann Surg,1989

2. A 10-year study of outcome following hepatic resection for colorectal liver metastases - The effect of evaluation in a multidisciplinary team setting;Lordan;Eur J Surg Oncol,2009